276 related articles for article (PubMed ID: 24066799)
1. Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines.
Cardama GA; Comin MJ; Hornos L; Gonzalez N; Defelipe L; Turjanski AG; Alonso DF; Gomez DE; Menna PL
Anticancer Agents Med Chem; 2014; 14(6):840-51. PubMed ID: 24066799
[TBL] [Abstract][Full Text] [Related]
2. Development of an Improved Guanidine-Based Rac1 Inhibitor with in vivo Activity against Non-Small Cell Lung Cancer.
Ciarlantini MS; Barquero A; Bayo J; Wetzler D; Dodes Traian MM; Bucci HA; Fiore EJ; Gandolfi Donadío L; Defelipe L; Turjanski A; Ramírez JA; Mazzolini G; Comin MJ
ChemMedChem; 2021 Mar; 16(6):1011-1021. PubMed ID: 33284505
[TBL] [Abstract][Full Text] [Related]
3. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
4. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
Zins K; Lucas T; Reichl P; Abraham D; Aharinejad S
PLoS One; 2013; 8(9):e74924. PubMed ID: 24040362
[TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin I inhibits Rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of Janus tyrosine kinase 2 and P-Rex1.
Lopez-Haber C; Kazanietz MG
Mol Pharmacol; 2013 May; 83(5):1141-54. PubMed ID: 23478800
[TBL] [Abstract][Full Text] [Related]
6. Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion.
Díaz J; Mendoza P; Ortiz R; Díaz N; Leyton L; Stupack D; Quest AF; Torres VA
J Cell Sci; 2014 Jun; 127(Pt 11):2401-6. PubMed ID: 24659799
[TBL] [Abstract][Full Text] [Related]
7. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
8. Trp(56) of rac1 specifies interaction with a subset of guanine nucleotide exchange factors.
Gao Y; Xing J; Streuli M; Leto TL; Zheng Y
J Biol Chem; 2001 Dec; 276(50):47530-41. PubMed ID: 11595749
[TBL] [Abstract][Full Text] [Related]
9. Novel inhibitors of Rac1 in metastatic breast cancer.
Hernández E; De La Mota-Peynado A; Dharmawardhane S; Vlaar CP
P R Health Sci J; 2010 Dec; 29(4):348-56. PubMed ID: 21261173
[TBL] [Abstract][Full Text] [Related]
10. Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells.
Hofbauer SW; Krenn PW; Ganghammer S; Asslaber D; Pichler U; Oberascher K; Henschler R; Wallner M; Kerschbaum H; Greil R; Hartmann TN
Blood; 2014 Apr; 123(14):2181-8. PubMed ID: 24501217
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells.
Zhao Y; Wang Z; Jiang Y; Yang C
Cancer Lett; 2011 Dec; 313(1):54-63. PubMed ID: 21943825
[TBL] [Abstract][Full Text] [Related]
12. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells.
Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM
J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412
[TBL] [Abstract][Full Text] [Related]
13. Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer.
Sosa MS; Lopez-Haber C; Yang C; Wang H; Lemmon MA; Busillo JM; Luo J; Benovic JL; Klein-Szanto A; Yagi H; Gutkind JS; Parsons RE; Kazanietz MG
Mol Cell; 2010 Dec; 40(6):877-92. PubMed ID: 21172654
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of guanine nucleotide exchange and Rac-mediated signaling revealed by a dominant negative trio mutant.
Debreceni B; Gao Y; Guo F; Zhu K; Jia B; Zheng Y
J Biol Chem; 2004 Jan; 279(5):3777-86. PubMed ID: 14597635
[TBL] [Abstract][Full Text] [Related]
15. Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.
Montalvo-Ortiz BL; Castillo-Pichardo L; Hernández E; Humphries-Bickley T; De la Mota-Peynado A; Cubano LA; Vlaar CP; Dharmawardhane S
J Biol Chem; 2012 Apr; 287(16):13228-38. PubMed ID: 22383527
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of Rac1 signaling regulation by guanine nucleotide exchange factors.
Marei H; Carpy A; Macek B; Malliri A
Cell Cycle; 2016 Aug; 15(15):1961-74. PubMed ID: 27152953
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7.
Abdelhaleem EF; Abdelhameid MK; Kassab AE; Kandeel MM
Eur J Med Chem; 2018 Jan; 143():1807-1825. PubMed ID: 29133058
[TBL] [Abstract][Full Text] [Related]
18. Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer.
Dokmanovic M; Hirsch DS; Shen Y; Wu WJ
Mol Cancer Ther; 2009 Jun; 8(6):1557-69. PubMed ID: 19509242
[TBL] [Abstract][Full Text] [Related]
19. GEFs: Dual regulation of Rac1 signaling.
Marei H; Malliri A
Small GTPases; 2017 Apr; 8(2):90-99. PubMed ID: 27314616
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatic analysis of RHO family of GTPases identifies RAC1 pharmacological inhibition as a new therapeutic strategy for hepatocellular carcinoma.
Bayo J; Fiore EJ; Dominguez LM; Cantero MJ; Ciarlantini MS; Malvicini M; Atorrasagasti C; Garcia MG; Rossi M; Cavasotto C; Martinez E; Comin J; Mazzolini GD
Gut; 2021 Jul; 70(7):1362-1374. PubMed ID: 33106353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
